Meru Capital Group’s Elevance Health ELV Stock Holding History

Meru Capital Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-46,000	Closed	-$7.61M	–	17
2017 Q1	$7.61M	Buy	+46,000	New	+$7.32M	2.41%	13

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Meru Capital Group's ELV Position: Q2 2017 in Review

Meru Capital Group sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 46,000 shares — an estimated $7.61M sold.

Meru Capital Group first reported a position in ELV in Q1 2017 and held it in 1 quarter. The position peaked at $7.61M in Q1 2017. 852 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

Meru Capital Group reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
Meru Capital Group sold 46,000 Elevance Health shares in Q2 2017, an estimated $7.61M.
Meru Capital Group first reported a position in Elevance Health in Q1 2017 and held it in 1 quarter.
Meru Capital Group's Elevance Health position peaked at $7.61M in Q1 2017.
852 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Meru Capital Group's 13F filing for Q2 2017, filed 11 Aug 2017.